General description
Docetaxel is a taxane derivative antineoplastic agent, used in the treatment protocols for many cancers.
INN
Docetaxel
ATC codes
Medicine type
Chemical agent
EML status history
First added in 2011
(TRS
965)
for
Malignant neoplasms of breast
Added in 2011
(TRS
965)
for
Malignant neoplasms of prostate
Added in 2011
(TRS
965)
for
Other specified malignant neoplasms of breast
Added in 2011
(TRS
965)
for
Unspecified malignant neoplasms of ill-defined or unspecified sites
Removed in 2015
(TRS
994)
for
Unspecified malignant neoplasms of ill-defined or unspecified sites
Wikipedia
DrugBank
Recommendations
Section
Cytotoxic medicines
- Parenteral > General injections > IV: 20 mg per mL; 40 mg per mL